OR WAIT null SECS
March 02, 2016
Gauging the adequate level and type of screening is the challenge when identifying relevant crystalline forms.
Scale-down modeling accelerates the development of downstream biopharma manufacturing processes.
Analytical laboratory equipment adapts for new realities of downsizing, outsourcing, and speed demands.
Hazardous reagents can prove to be faster, simpler, cheaper, and greener.
The pharma company revealed in a fourth quarter call that it will improve its cell-culture capabilities by focusing on the use of naïve, highly proliferative cells to manufacture its CAR-T drug candidate.
February 11, 2016
Ashland Chemical’s Calvert City, KY, facility is the first in the US to receive EXCiPACT certification for GMPs of pharmaceutical excipients.
February 02, 2016
Scale-down modeling is instrumental in supporting the development of downstream biopharma manufacturing processes.
Hazardous reagents can simplify processes and provide higher yields and purities.
The chemical distribution industry has formed an international chemical trade association to address global issues.
Choosing the right excipient manufacturer can help ensure the use of quality excipients.